WWM
PPH icon

WT Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

WT Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.88M Buy
53,786
+3,402
+7% +$352K 1.63% 18
2026
Q1 		$5.23M Buy
50,384
+8,252
+20% +$879K 1.56% 19
2025
Q4 		$4.35M Sell
42,132
-3,496
-8% -$340K 1.25% 24
2025
Q3 		$4.12M Sell
45,628
-969
-2% -$84.9K 1.19% 27
2025
Q2 		$4.1M Sell
46,597
-5,095
-10% -$442K 1.21% 25
2025
Q1 		$4.71M Sell
51,692
-4,998
-9% -$450K 1.53% 22
2024
Q4 		$4.89M Buy
56,690
+3,030
+6% +$274K 1.54% 18
2024
Q3 		$5.08M Buy
53,660
+3,424
+7% +$325K 1.62% 18
2024
Q2 		$4.6M Buy
50,236
+9,475
+23% +$846K 1.57% 18
2024
Q1 		$3.7M Buy
40,761
+1,148
+3% +$101K 1.32% 20
2023
Q4 		$3.22M Buy
39,613
+4,155
+12% +$326K 1.27% 22
2023
Q3 		$2.83M Buy
35,458
+530
+2% +$42.7K 1.21% 17
2023
Q2 		$2.75M Buy
34,928
+2,597
+8% +$203K 1.14% 23
2023
Q1 		$2.51M Buy
+32,331
New +$2.49M 1.08% 25

Other funds holding PPH

AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
RBC
Rye Brook Capital Greenwich, Connecticut $143M AUM 33.65% 1-Year Est. Return
FF
Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return
CWRP
Cassady Wealth & Retirement Planning Henderson, Nevada $215M AUM
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
AWA
ARQ Wealth Advisors Scottsdale, Arizona $807M AUM 19.58% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return
WF
Warner Financial Bethesda, Maryland $340M AUM 22.81% 1-Year Est. Return
TCM
Telos Capital Management San Diego, California $1.13B AUM 27.95% 1-Year Est. Return

WT Wealth Management's PPH Position: Q2 2026 in Review

WT Wealth Management increased its VanEck Pharmaceutical ETF (PPH) stake by 6.8% in Q2 2026, buying an estimated $352K and bringing the position to 53,786 shares worth $5.88M. The position accounts for 1.63% of the portfolio, ranked #18.

WT Wealth Management first reported a position in PPH in Q1 2023 and has held it in 14 quarters since. 38 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • WT Wealth Management held 53,786 shares of VanEck Pharmaceutical ETF worth $5.88M as of Q2 2026.
  • WT Wealth Management bought 3,402 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $352K.
  • VanEck Pharmaceutical ETF made up 1.63% of WT Wealth Management's portfolio in Q2 2026, its #18 holding.
  • WT Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q1 2023 and has held it in 14 quarters since.
  • 38 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on WT Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.